Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Juli 2025 08:36 ET | Quelle: Proteros biostructures GmbH

Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration

Joint research program targets new treatments for life-threatening complication of brain hemorrhage An international discovery collaboration is harnessing AI-powered drug discovery to develop a...
06. September 2023 04:00 ET | Quelle: Proteros biostructures GmbH

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine

Multi-target research partnership for drug discovery in oncology and painAssembly of novel high-diversity small molecule library Library collection distinguished by novel unique design concepts based...
09. Januar 2023 04:00 ET | Quelle: Proteros biostructures GmbH

Proteros receives minority investment from private equity firm Inflexion

MARTINSRIED, Germany and MUNICH, Germany, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Proteros biostructures GmbH, a leading German-based, founder-led contract research organization focused on early-stage...
25. Oktober 2022 08:00 ET | Quelle: Proteros biostructures GmbH

Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engineProteros to support Adrestia in the discovery of first-in-class drugs for intractable genetic diseasesSignals...